Stocks › HAE
HAEMONETICS CORP
HAE·NYSE·
United States·USD
$103.52
-1.16 (-1.11%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
HAE
HAEMONETICS CORP · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
HAES&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of HAE by members of U.S. Congress · 17 on record
Whale Activity
Position changes in HAE reported for 2026-06-30 by 13 tracked institutional filers
- Increased6
- New0
- Held0
- Decreased4
- Closed0
- No prior filing3
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 5.9M | $443.2M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.5M | $191.0M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | $154.5M | decreased |
| CITADEL ADVISORS LLC | 1.5M | $113.3M | increased |
| MILLENNIUM MANAGEMENT LLC | 570.4K | $42.8M | increased |
| RENAISSANCE TECHNOLOGIES LLC | 130.0K | $9.8M | increased |
| Point72 Asset Management, L.P. | 109.2K | $8.2M | increased |
| Bridgewater Associates, LP | 59.7K | $4.5M | increased |
| Expect Equity LLC | 41.0K | $3.1M | — |
| BEACON INVESTMENT ADVISORS LLC | 37.1K | $2.8M | — |
| D. E. Shaw & Co., Inc. | 36.0K | $2.7M | decreased |
| Nierenberg Investment Management Company, LLC | 26.3K | $2.0M | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by HAE insiders, by quarter · Form 4
Recent Insider Transactions
1,851 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Maunsell Farris MaryanneVP, Chief Accounting Officer | Tax withholding | −259 | $71.28 | $18K | Jun 5, 2026 | Form 4 ↗ |
| Miller Laurie A.SVP, Human Resources | Tax withholding | −313 | $71.28 | $22K | Jun 5, 2026 | Form 4 ↗ |
| Basil Michelle LEVP and General Counsel | Grant / award | +28.4K | — | — | May 15, 2026 | Form 4 ↗ |
| Basil Michelle LEVP and General Counsel | Tax withholding | −2,913 | $56.29 | $164K | May 15, 2026 | Form 4 ↗ |
| Chan FrankEVP, Chief Operating Officer | Grant / award | +27.5K | — | — | May 15, 2026 | Form 4 ↗ |
| Chan FrankEVP, Chief Operating Officer | Tax withholding | −546 | $56.29 | $31K | May 15, 2026 | Form 4 ↗ |
| DArecca JamesEVP, Chief Financial Officer | Grant / award | +29.3K | — | — | May 15, 2026 | Form 4 ↗ |
| DArecca JamesEVP, Chief Financial Officer | Tax withholding | −2,505 | $56.29 | $141K | May 15, 2026 | Form 4 ↗ |
| Maunsell Farris MaryanneVP, Chief Accounting Officer | Grant / award | +2,220 | — | — | May 15, 2026 | Form 4 ↗ |
| Maunsell Farris MaryanneVP, Chief Accounting Officer | Tax withholding | −197 | $56.29 | $11K | May 15, 2026 | Form 4 ↗ |
| Galvin RoyEVP, Chief Commercial Officer | Grant / award | +27.5K | — | — | May 15, 2026 | Form 4 ↗ |
| Galvin RoyEVP, Chief Commercial Officer | Tax withholding | −879 | $56.29 | $49K | May 15, 2026 | Form 4 ↗ |
| Miller Laurie A.SVP, Human Resources | Grant / award | +13.3K | — | — | May 15, 2026 | Form 4 ↗ |
| Miller Laurie A.SVP, Human Resources | Tax withholding | −948 | $56.29 | $53K | May 15, 2026 | Form 4 ↗ |
| Simon, ChristopherPresident & CEO · Director | Grant / award | +78.3K | — | — | May 15, 2026 | Form 4 ↗ |
| Simon, ChristopherPresident & CEO · Director | Tax withholding | −9,681 | $56.29 | $545K | May 15, 2026 | Form 4 ↗ |
| DArecca JamesEVP, Chief Financial Officer | Tax withholding | −655 | $59.26 | $39K | May 1, 2026 | Form 4 ↗ |
| KROLL MARK WDirector | Purchase | +1,400 | $70.56 | $99K | Nov 10, 2025 | Form 4 ↗ |
| Galvin RoyEVP, Chief Commercial Officer | Tax withholding | −145 | $50.01 | $7K | Oct 31, 2025 | Form 4 ↗ |
| Miller Laurie A.SVP, Human Resources | Tax withholding | −238 | $49.95 | $12K | Sep 17, 2025 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding HAE · SEC Form N-PORT
This section is temporarily unavailable, reload in a minute.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- AQR Capital Management Holdings, LLCSCHEDULE 13G/A · passive (13G) · 2.3M shares5.0%
Aug 12, 2026 · ↗ - AQR Capital Management, LLCSCHEDULE 13G/A · passive (13G) · 2.3M shares5.0%
Aug 12, 2026 · ↗ - Jeremy Steven KahanSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗ - Michael Kevin KahanSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗ - North Peak Capital Ultra Fund, LPSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗ - North Peak Capital Alpha Fund, LPSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗ - North Peak Capital Partners II, LPSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗ - North Peak Capital Partners, LPSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗ - North Peak Capital GP, LLCSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗ - North Peak Capital Management, LLCSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
May 13, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming HAEMONETICS CORP as client
No lobbying filings found naming HAEMONETICS CORP as the client.
Government Contracts
Federal awards to haemonetics · USAspending
$456KAwarded · 9 contracts on record
- Department of Veterans AffairsTEG ANALYZERS$24K
Oct 10, 2024 · ↗ - Department of DefenseVASCADE MVP.$84K
Jun 2, 2026 · ↗ - Department of Veterans AffairsEXPRESS REPORT: NX ORDERS PLACED DURING THE MONTH OF AUGUST, 2026$27K
Aug 1, 2026 · ↗ - Department of Veterans AffairsEXPRESS REPORT: NX ORDERS PLACED DURING THE MONTH OF APRIL, 2026$23K
Apr 1, 2026 · ↗ - Department of DefenseHAEMONETICS CORPORATION PROVIDES THE ARTERIAL AND VENOUS CLOSURE SHEATHS REQUIRED FOR CARDIAC ELECTROPHYSIOLOGY PROCEDURES WHICH ENABLE SAME$88K
Feb 12, 2026 · ↗ - Department of Veterans AffairsEXPRESS REPORT: NX ORDERS PLACED DURING THE MONTH OF FEBRUARY 2026$50K
Feb 1, 2026 · ↗ - National Aeronautics and Space AdministrationPORTABLE BLOOD ANALYZERS$132K
Jul 1, 2026 · ↗ - Department of Veterans AffairsTEG6 PLATINUM SERVICE$12K
Sep 16, 2024 · ↗
U.S. Patents
Recent USPTO applications naming HAEMONETICS CORP
No USPTO patent applications found for HAEMONETICS CORP.
Annual Financials
From HAE's 10-K filings · XBRL
No annual XBRL figures on record for HAE. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 2-for-1Stock splitDec 3, 2012
- 2-for-1Stock splitJan 11, 1993
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 7.01Reg FD disclosureAug 18, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
EDGAR ↗ - 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteJul 28, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureJun 5, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
EDGAR ↗ - 8-K · Items 5.02Officer / director changeMay 1, 2026
EDGAR ↗
About HAEMONETICS CORP
From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersBOSTON, MA
IncorporatedMA
SEC CIK0000313143 ↗




